{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:14Z","timestamp":1786986854116,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003213","name":"Beijing Municipal Education Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003213","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.clineuro.2020.106187","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T11:39:56Z","timestamp":1598441996000},"page":"106187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies"],"prefix":"10.1016","volume":"197","author":[{"given":"Yu","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0006-2933","authenticated-orcid":false,"given":"Yuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clineuro.2020.106187_bib0005","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.clineuro.2020.106187_bib0010","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clineuro.2020.106187_bib0015","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.clineuro.2020.106187_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann Neurol"},{"issue":"14","key":"10.1016\/j.clineuro.2020.106187_bib0025","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.clineuro.2020.106187_bib0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome","volume":"87","author":"Ari\u00f1o","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clineuro.2020.106187_bib0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.clineuro.2020.106187_bib0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.clineuro.2020.106187_bib0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/ene.13324","article-title":"Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies-a national cohort study","volume":"24","author":"Celicanin","year":"2017","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.clineuro.2020.106187_bib0050","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.3892\/ol.2016.4922","article-title":"Paraneoplastic Morvan\u2019s syndrome following surgical treatment of recurrent thymoma: A case report","volume":"12","author":"Gali\u00e9","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clineuro.2020.106187_bib0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12883-016-0555-x","article-title":"A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Neurol"},{"key":"10.1016\/j.clineuro.2020.106187_bib0060","unstructured":"Dong L.L., Guan H.Z., Huang Y., et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 41 (3) (2019) 344\u2013350."},{"issue":"12","key":"10.1016\/j.clineuro.2020.106187_bib0065","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jamaneurol.2018.2681","article-title":"Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia","volume":"75","author":"Vincent","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clineuro.2020.106187_bib0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2018.05.020","article-title":"Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1\/CASPR2 antibodies","volume":"391","author":"Yeo","year":"2018","journal-title":"J Neurol Sci"},{"issue":"10","key":"10.1016\/j.clineuro.2020.106187_bib0075","first-page":"1311","article-title":"Acquired neuromyotonia heralding recurrent thymoma in myasthenia gravis","volume":"70","author":"Fleisher","year":"2013","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.clineuro.2020.106187_bib0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1212\/WNL.0000000000004861","article-title":"Morvan syndrome associated with CASPR2 and LGI1 antibodies in a child","volume":"90","author":"Nikolaus","year":"2018","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.clineuro.2020.106187_bib0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ana.25310","article-title":"LGI1 and CASPR2 neurological autoimmunity in children","volume":"84","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.clineuro.2020.106187_bib0090","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/dmcn.14179","article-title":"Acquired neuromyotonia in children with CASPR2 and LGI1 antibodies","volume":"61","author":"Surana","year":"2019","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"10.1016\/j.clineuro.2020.106187_bib0095","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1212\/WNL.0000000000001922","article-title":"Clinical relevance of voltage-gated potassium channel\u2013complex antibodies in children","volume":"85","author":"Hacohen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2020.106187_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577008","article-title":"LGI1 and CASPR2 autoimmunity in children: Systematic literature review and report of a young girl with Morvan syndrome","volume":"335","author":"Nosadini","year":"2019","journal-title":"J Neuroimmunol"},{"issue":"20","key":"10.1016\/j.clineuro.2020.106187_bib0105","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMcp066837","article-title":"Clinical practice. The syndrome of inappropriate antidiuresis","volume":"356","author":"Ellison","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.clineuro.2020.106187_bib0110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4103\/0976-3147.188638","article-title":"Morvan\u2019s syndrome with anti contactin associated protein like 2-voltage gated potassium channel antibody presenting with syndrome of inappropriate antidiuretic hormone secretion","volume":"7","author":"Sharma","year":"2016","journal-title":"J Neurosci Rural Pract"},{"issue":"5","key":"10.1016\/j.clineuro.2020.106187_bib0115","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.clineuro.2020.106187_bib0120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.clineuro.2020.106187_bib0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ene.13180","article-title":"Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur J Neurol"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720305308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720305308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:36:33Z","timestamp":1759588593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720305308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":25,"alternative-id":["S0303846720305308"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106187","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.106187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106187"}}